I’m on the same page, the timeline isn’t as critical as getting the validation trial right. If that goes well, the rest should fall into place, including FDA approval and eventual commercialisation. Even if it takes a couple of years, it’ll be worth the wait.
You’re spot on about management too. They’ve played things smart, keeping things lean while pushing towards commercialisation. The idea of this tech becoming a new major imaging method alongside Ultrasound, CT, and MRI is exciting. Lots to look forward to!
EMvision Research Notes, page-2615
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
0.065(3.27%) |
Mkt cap ! $175.3M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.05 | $2.00 | $35.10K | 17.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1206 | $2.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.05 | 5674 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |